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                                                  INTRODUCTION 
 
 Solitary nodule of the thyroid of discrete thyroid swelling is a common 
clinical entity and the incidence increases with age.  
 About half of the patients with palpable nodular goitre are diagnosed as 
multinodular goitre.The importance of this clinical entity is that 10-20% of solitary 
nodules of the thyroid  could be malignant.  
 The approach to thyroid nodule management is a selective one, utilizing 
continually Improving diagnostic techniques to reliably identify patients with 
malignancy and certain benign conditions that require surgery thereby avoiding 
unnecessary thyroidectomy for all nodules. 
 A potentially curable cancer normally presents as a thyroid nodule and 
thereby the study of a solitary nodule gains importance.        
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AIM OF THE STUDY 
1. To study the epidemiology of the solitary nodule of the thyroid. 
2. To study the role of fine needle aspiration cytology in the management of 
solitary  nodule of the thyroid.      
3. To study the incidence of malignancy in solitary nodule of the thyroid.  
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                              MATERIALS AND METHODS 
 
CASE SELECTION 
 All patients admitted with a solitary nodule of the thyroid.  
EXCLUSION CRITERIA 
 1. Patients with severe comorbid illness. 
 2. Patients with solitary nodule of thyroid and regional lymph adenopathy. 
MATHERIALS AND METHODS 
Place of study : Thanjavur medical college hospital, Thanjavur. 
Period of study : 01.09.2014 to 31.08.2016  2 years 
No of patients : 100 
 A total of (110) consecutive patients admitted at TMCH, Thanjavur with 
solitary nodule of the thyroid and only 100 of the patients who satisfied the above 
criteria were included in the study.  
LIMITATION OF THE STDUY  
 Many patients are lost to follow up after 2 reviews and the exact incidence 
of post operative hypothyroidism could not be evaluated.  
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REVIEW OF LITERATURE 
 
HISTORICAL BACKGROUND  
 The word Goitre comes from latin word meaning as gutter,throat and have 
been described since 2700 B.C.  
 Hieronymus Fabricius ab Aquapendente a famous anatomist  described that 
goiters arose from the thyroid gland. 
 The word thyroid gland comes from Greek meaning as shield-like is 
however coined by Thomas Wharton in his Adrenographia.  
 In the year 1776, Albrecht Von Haller said that thyroid gland is a ductless 
gland. 
 Surgery for thyroid gland in patient having goitre was first introduced by 
Roger Frugardi in the year 1170. 
 Emil Theodor Kocher a swiss physician and Christian albert Theodor 
Billroth a surgeon had done various thyroid surgeries with increasingly successful 
outcome. 
 In the year 1909, Kocher was given  the Nobel Prize for his work in “the 
Physiology, Pathology and Surgery of the thyroid gland”.  
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EMBRYOLOGY  
 The thyroid gland arises as an outpouching of the primitive foregut around 
the third week of gestation, in the vicinity of the foramen cecum of tongue.  
          From the floor of the pharyngeal anlage the endodermal cells thicken to form 
the medial thyroid anlage which gives arise to the hyoid bone and larynx after 
descend in anterior region of neck where it is connected to the foramen cecum by 
an epithelial lined duct named  thyroglossal duct. 
 Thyroid follicular cells are arises from epithelial cells anlage. Paired lateral 
anlages arises from the fourth branchial pouch which fuses with the median anlage 
at approximately the 5th week of gestation.  
         Calcitonin producing parafollicular or C cells which is arises from lateral 
anlages(neuroectodermal origin), which lie in the postero – superior region of the 
gland. Thyroid follicles are appears by eighth week and colloid formation begins 
by the eleventh week of gestational period. 
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ANATOMY  
MORPHOLOGY  
 The thyroid gland occupies the centre of the visceral compartment of the 
neck lying over the trachea just above the thoracic inlet. Normal gland weighs 20 -
25g.  
 The gland has two lobes connected by an isthmus shaped like butterfly in the 
midline just  inferior to cricoid cartilage,adherent to the anterolateral aspect of the 
cervical trachea from the level of the thyroid cartilage to the fifth or sixth tracheal 
ring.  
  The most distal end of the thyroglossal duct persist as pyramidal lobe and  is 
present  in about one half of the normal individuals.  
 The upper part of thyroid lobes arises at level of middle of the thyroid 
cartilage and lie near  to the carotid sheaths and sternocleidomastoid muscles 
which lies laterally. It is enveloped by the deep cervical fascia that forms the false 
capsule. The true capsule of thyroid is a thin, densely adherent fibrous layer that 
sends out septa that invaginate into the gland forming pseudolobules, and is 
condensed into the posterior suspensory or Berry’s ligament near the cricoid 
cartilage and upper tracheal rings.  
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 The infrahyoid muscles(strap muscles) which is a group of four muscles 
sternohyoid,thyrohoid, sternothyroid and superior belly of the omohyoid which is 
placed anteriorly and are innervated by the ansacervicalis except thyrohyoid 
muscles which is supplied by hypoglossal nerve. 
 
BLOOD SUPPLY   
ARTERIAL SUPPLY 
 The Superior thyroid arteries arise from the external carotid arteries of same 
side which later divide into anterior and posterior branches at the apex of the 
thyroid gland.  
 The inferior thyroid arteries are derived from the thyrocervical trunk.  
 A thyroidea ima artery arises directly from the aorta in 1 -4% of individuals.  
 Extensive anastomoses occur between the main thyroid arteries and branches 
of the tracheal arteries and the oesophageal arteries.  
 
VENOUS DRAINAGE  
 Multiple tiny surface veins over the thyroid gland  which unites to form 
three sets of veins, the superior, middle and inferior thyroid veins.  
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 Of which superior and middle thyroid veins drain directly into the internal 
jugular veins whereas the inferior veins often form a plexus, which drains into the 
brachiocephalic veins.  
 
NERVE SUPPLY 
 Sympathetic innervations of the thyroid gland is derived from the superior 
and middle cervical sympathetic ganglia, which enter the gland with the blood 
vessels and are vasomotor in action.  
 Parasympathetic fibers are arises from the vagus nerve and reached the gland 
via branches the laryngeal nerves.  
LYMPHATIC DRAINAGE 
 The thyroid gland is supplied by more of  lymphatics vessels. Both thyroid 
lobes are communicated by intraglandular lymphatic vessels through the isthmus 
of thyroid and which also drain the perithyroidal structures and the surrounding  
lymph nodes.  
 Regional lymph nodes of thyroid gland includes pretracheal, paratracheal, 
perithyroidal, superior mediastinal, retro pharyngeal, esophageal , posterior 
triangle of neck, submaxillary triangle nodes,upper, middle and lower jugular chain 
nodes may gets involved in the metastatic activity of the malignancies of thyroid 
gland.  
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THE IMPORTANT SURGICAL RELATIONS OF THE THYROID GLAND  
The External Laryngeal Nerve  
 Superior laryngeal nerve gives arises a branch named as external laryngeal 
nerve which further descends over the fascia of the inferior pharyngeal constrictor, 
which runs near the superior vascular pedicle of the thyroid gland and then leaves 
this at a variable height above the gland to travel medially to pierces the 
cricothyroid muscle viz the tensor of the vocal cord.  
 
The Recurrent Laryngeal Nerve  
 Vagus nerve gives  arises to reccurrent laryngeal nerve which 
embryologically related to vessels of  the fourth aortic arch. Because of the descent 
of these vessels which later forms the subclavian artery on the right side and the 
aotic arch on the left side, the recurrent nerves  runs distally an upward direction to 
reach their vocal cord. The nerves usually lie in the trachea – oesophageal groove 
and bear a numerous relationship to the branches of the inferior thyroid artery 
before entering into the larynx.  
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The Parathyroid glands  
 The number of parathyroids vary from 2 – 6, but in 80 percent of cases there 
are 4 (2 on each side) where most of the blood supply comes from the branches of 
the inferior thyroid artery.Parathyroid glands usually seen around 1cm of the 
junction of the inferior thyroid artery and the recurrent laryngeal nerve. The 
superior glands are usually seen posterior to the recurrent laryngeal nerve whereas 
the inferior glands are seen anterior to the reccurent laryngeal nerve.  
 
Thyroid Histology 
 Microscopically, the thyroid is divided into lobules that contain 20 to 40 
follicles. The follicles are 30 um in diameter and 3x106 in number and lined by 
cuboidal epithelial cells and it contains a central pool of colloid. Calcitonin is 
hormone secreated by C cells or parafollicular cells which is in the interfollicular 
stroma in the upper poles of the thyroid gland.  
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                                             HISTOLOGY 
 
 
                                           NORMAL THYROID 
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THYROID PHYSIOLOGY 
IODINE METABOLISM  
 The average daily iodine requirement is 0.1mg, which can be derived from 
foods such as fish, milk and eggs. Iodine is absorbed in the stomach and jejunum 
after conversion of iodine to iodide and into the blood stream. 90% of the body’s 
iodine stored in the thyroid gland which accounts for one-third of the plasma 
iodine loss. The remaining plasma iodine is cleared via renal excretion.  
 
NORMAL THYROID PHYSIOLOGY 
Tri-iodothyronine(T3) and thyroxine(T4) are the home secreted by the thyroid 
gland. Dietary requirement of iodine per day is 100-200 mcg. Sources of iodine are 
milk , dairy products and sea food including fish. 
STEPS INVOLVED IN THE SYNTHESIS OF THESE HORMONES 
1.Iodide trapping from the blood into the thyroid, is the first step in the formation 
of T3 andT4. 
2.Oxidation of iodide to inorganic iodine. This step need the enzyme peroxidase. 
          Drugs which block this stage are sulfonamide, PAS,carbimazole, 
propylthiouracil, etc. 
 
 
13 
 
 
3.Formation of iodotyrosines 
        Iodine+thyrosine=Monoiodotyrosine and Diiodotyrosine. 
  This step is inhibited by thiourea group of drugs i.e carbimazole. 
 
4.Coupling reactions 
     Coupling of two molecules of DIT results in T4 and one molecule of DIT and 
MIT results in T3. This stage is blocked by carbimazole. The hormone combine 
with globulin to form a colloid- thyroglobulin. They are stored in the thyroid gland 
and released as and when required. 
     T3 is an important physiological hormone and fast acting. T4 is slow acting 
hormone and takes about 4-14 days to act. 
 
  
14 
 
 
THYROID HORMONE FUNCTION  
 Thyroid hormones affect almost every system in the body.  
 They are important for fetal brain development and skeletal maturation. It 
increases the basal metabolic rate.  
 
FUNCTIONS OF THYROID HORMONES  
 Thyroid hormones act predominantly via a nuclear thyroid receptor (TR), 
which modulates gene synthesis of the cell which in turn increases protein 
synthesis. They are essentially catabolic in nature and  
❖ Increase the glucose absorption from gut  
❖ Mobilize the liver glycogen  
❖ Promote gluconeogenesis  
❖ Increase appetite  
❖ Increase heart rate  
❖ Increase gut motility  
❖ Decrease body weight  
❖ Decrease menstrual flow  
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SOLITARY NODULE OF THE THYROID  
DEFINITION  
 Solitary nodule of the thyroid is defined as the only nodule that is detectable 
clinically and by other means in an otherwise morphologically normal thyroid 
gland.  
 
EPIDEMIOLOGY  
INCIDENCE  
 3-4% of adult  
 More common in females,: = 1:3. 15% are malignant which is more 
common after 50yrs.  
 30-40% are follicular Adenomas.  
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CLINICAL AND PATHOLOGICAL CLASSIFICATION OF THYROID 
NODULES 
● NON – NEOPLASTIC NODULES  
HYPERPLASTIC  
 Spontaneous  
 Compensatory after partial thyroidectomy  
 Hemiagenesis with contralateral lobe hyperplasia  
 
INFLAMMATORY  
 Acute bacterial thyroiditis  
 Subacute thyroiditis  
 Lymphocytic thyroiditis  
● NEOPLASTIC NODULES  
BENIGN  
 Adenoma  
 Cyst  
  Simple  
  Complex  
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MALIGNANT  
      Primary  
 Papillary Carcinoma  
 Follicular Carcinoma  
 Anaplastic Carcinoma  
 Medullary Carcinoma  
 Lymphoma  
         Thyroid Metastasis From Other Primaries  
         (Kidney, Breast, Lung, Melanoma)  
● Toxic nodules  
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CLINICAL HISTORY  
❖ Age and Sex of the patient  
❖ Details regarding the nodule such as the time of onset, progression of size 
and associated symptoms such as pain,fever, difficulty in swallowing, 
breathlessness. 
❖ Pain is an unusual symptom, occurs in intrahyroidal hemorrhage in a benign 
nodule, thyroiditis or malignancy.  
❖ Hoarseness of voice is a omnious symptom 
❖ History suggestive of hypo functioning or hyper functioning of the thyroid 
gland.  
❖ Patient having high chance of malignancy if chlidhood exposure of ionizing 
radiation, family history of thyroid malignancies and other malignancies 
associated with thyroid. 
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PHYSICAL EXAMINATION  
1.  Visible and palpable swelling in the thyroid region.  
2. Rest of the gland not enlarged.  
3. Moves up with deglutition.  
4. Nature of the Nodule – site, size, shape, consistency.  
5. Regional lymph nodes  
6. Features of thyroid dysfunction  
7. Clinical features suggestive of pathological change in nodule like 
tenderness.  
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EVALUATION OF PATIENTS WITH THYROID NODULE TESTS OF 
THYROID FUNCTION 
Serum TSH  
 Serum TSH assay is the best marker for the diagnosing hyperthyroidism and 
hypothyroidism  and also for managing T4 replacement and suppressive therapy, 
the normal level being 0.5 – 5 uU/ml.  
SERUM T4 & T3 
 Total T4 level reflects the output from the thyroid gland and increase in 
hyperthyroid, normal level being 55 – 150 nmol/L.  
 Total T3 level in the non-stimulated gland are represents the peripheral 
thyroid hormone metabolism and not suitable as a general screening test. It is 
important in clinically hyperthyroid patients with normal T4 levels who may have 
T3 thyrotoxicosis. Total T3 levels are often increased in early hypothyroidism & 
normal level being 1.5 – 3.5 n mol/L.  
Free T4 and Free T3  
 Normal value being, 
 Free T4 – 12 – 28 pmol/L  
 Free T3 – 3 – 9 pmol/L  
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Thyrotropin – Releasing Hormone (TRH)  
 This test is useful to evaluate pituitary TSH secretory function and is 
performed by administering 500ug of TRH intravenously and measuring TSH 
levels after 30& 60 minutes. In a normal individual TSH levels should increase at 
least 6 uIU/mL from the baseline.  
Thyroid Antibodies  
 Thyroid antibodies includes antimicrosomal or antithyroid peroxidase, anti 
thyroglobulin and thyroid stimulating immunoglobulin. 
 Anti – Tg and anti – TPO antibody levels indicate an autoimmune 
thyroiditis. They are increased is 80% of patients with Hashimoto’s thyroiditis, 
toxic diffuse goitre,multi- nodular goiter and occasionally with thyroid neoplasms. 
Thyroid stimulating immunoglobulin is elevated in toxic diffuse goitre.  
 Excessive Thyroglobulin level seen in cases of thyroiditis, Graves’ disease 
and toxic nodular goiter.  Serum thyroglobulin levels is best marker  in cases of 
patient with recurrence of diseases differentiated thyroid malignancies particularly 
after total thyroidectomy and radioactive iodine ablation.  
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THYROID IMAGING  
ULTRA SOUND 
 Ultrasound is an best, non invasive method of  imaging  the thyroid gland 
and it has a another advantage of no radiation exposure. Ultrasound imaging 
helpful in differentiating  solid from cystic lesion  and also providing information 
about size and multicentricity and can be used to assess for cervical 
lymphadenopathy and to USG guided fine – needle aspiration cytology.  
CT / MRI SCAN  
 These studies provide excellent imaging of the thyroid gland and adjacent 
nodes and are particularly useful in diagnosing the substernal goiters and their 
relationship to the trachea and vascular structures. Non contrast CT scans should 
be obtained in patients who are likely to require subsequent radioactive iodine 
therapy.  
RADIO ISOTOPE IMAGING 
 Radioisotopes imaging used to screen and also treat mestastatic diseases of 
well differentiated carcinoma of thyroid. The images provide details regarding  
size,shape of the gland and also functional activity of the thyroid gland.  
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 Areas of the thyroid gland shows less radioactivity than the surrounding area 
are termed as “cold”, whereas areas that shows more radioactivity are termed as 
“hot”. The risk of malignancy is more  in case of cold lesions ( 20%) than in hot or 
warm lesions (<5%).  
 Technetium – 99m pertechnetate is taken up by the thyroid and quickly 
washes out of the gland before being organified. It has a shorter half life and is 
particularly sensitive for nodal metastatases.  
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MAGNETIC RESONANCE IMAGING  
 
 
 
 
 HYPERINTENSE LESION RIGHT LOBE – ADENOMA 
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TECHNETIUM 99 M NUCLEAR SCAN 
 
 
 
COLD NODULE – RIGHT LOBE OF THYROID 
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 Recently Thallium – 201 scan was reported as best diagnostic method in 
differentiating benign and malignant thyroid lesion.  
 More recently, 18F – fluorodeoxy glucose positron emission tomography is 
the best diagnostic modality to diagnose metastatic diseases in whom other 
imaging studies are negative. This method is not widely available and is more 
expensive.  
 
FINE NEEDLE ASPIRATION CYTOLOGY 
 Fine needle aspiration cytology (FNAC) has best  tool for diagnosing the 
thyroid lesion under ultrasound guidance. 
               FNAC results classified into benign,suspicious, malignant and non 
diagnostic lesion. Non diagnostic cytology is to be repeated and often indicates a 
follicular neoplasm. 
     Risk of malignancy in the benign lesion of thyroid such as cyst and nodule  
is <3% but in suspicious cytology the risk varies from 10 – 20%. FNA cytology is 
less reliable in follicular or hurthle cell neoplasm and in patients with history of 
head and neck irradiation or a family history of thyroid cancer because of a higher 
likelihood of multifocal lesions.  
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OTHER INVESTIGATIONS  
Serum calcitonin  
 Serum Calcitonin levels is investigation of choice in  patients with medullary 
thyroid cancer or a family history of  MEN II (Multiple Endocrine Neoplasia).  
TUMOR MARKERS  
 Sr. TSH  
 Sr. Thyroglobulin  
 Sr. Calcitonin  
 Tumor markers have diagnostic and prognostic value.  
URINE ANALYSIS  
 A 24-hour urine collection with measurement of levels of vanillyl mandelic 
acid, meta – nephrine and catecholamine in patients with medullary thyroid cancer 
to rule out coexisting pheochromocytoma.  
RET Oncogene mutation  
 Approximately 10% of patients with familiar MTC and MEN 2A have a 
denovo RET mutation so that their children are at risk for thyroid cancer.  
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MANAGEMENT 
1. Thyroid cysts 
 Simple thyroid cysts < 4 cm in diameter –aspiration 
 75% of cysts completely resolve. 
 Simple cyst > 4 cm in diameter, complex cysts and if cyst persists after 3 
attempts of aspiration, ipsilateral hemi thyroidectomy is recommended.  
 
2. Collioid Nodule  
 Colloid Nodule < 3cm in diameter – observation  
 (or) suppression therapy with L – thyroxine  
 To maintain serum TSH between  
 0.1 and 1.0 uU/ml  
 Large nodules and when the nodule enlarges, causes pressure symptoms or 
for cosmetically poor appearance, either hemi thyroidectomy or isthmusectomy 
depending on the site of nodule is done.  
 3. Adenomas are managed by ipsilateral hemi thyroidectomy and frozen section 
analysis to rule out malignancy and if positive, total thyroidectomy is done.  
 
29 
 
4. Malignant tumors are treated by total thyroidectomy. During thyroidectomy 
enlarged ipsilateral neck nodes should be removed. Lymph node metastasis in the 
lateral neck should be managed with modified radical or functional neck 
dissection. Prophylactic neck node dissection is not necessary in patients with 
papillary thyroid cancer.  
 In case of medullary thyroid carcinoma central compartment nodes are 
frequently involved and a bilateral central neck node dissection should be routinely 
performed.  
 In Anaplastic carcinoma in which the tumor may be fixed to surrounding 
structures causing pressure symptoms, tracheostomy may be needed to alleviate 
airway obstruction.  
5. Lymphoma  
 Combination Chemo therapy with CHOP regimen that includes 
cyclophosphamide, Doxorubicin, vincristine and prednisolone ensures a rapid 
response and an improved survival.  
6. Metastatic carcinoma  
 Ipsilateral hemi thyroidectomy is helpful in many patients depending on the 
status of their primary tumor.  
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7. An exception to the General rule is the patient who has had previous irradiation 
of the thyroid gland or has a family history of thyroid cancer. Total or near-total 
thyroidectomy is recommended in these patients as the incidence of thyroid cancer 
is high (40%) and the reliability of FNAC is decreased on this setting.  
8. Toxic nodules  
 Small nodules < 3 cm size can be managed with antithyroid medications and 
Radioactive Iodine ablation.  
 Larger nodules and toxic nodules in young patients are treated by surgery 
(ipsilateral hemi thyroidectomy) after adequate preparation of the patient before 
surgery.  
Indications for surgery in solitary nodule of the thyroid  
● NEOPLASIA (FNAC Positive, Clinical Suspicion)  
Age (younger than 20 or older than 45)  
Male sex  
Hard texture  
Fixity  
Recurrent laryngeal nerve palsy  
Lymphadenopathy  
Large nodule >4cm  
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● TOXIC ADENOMA  
● PRESSURE SYMPTOMS  
● COSMESIS  
● PATIENT’S WISHES 
 
Thyroid surgery  
Pre operative preparation  
 1. Vocal cord assessment by indirect laryngoscopy  
 2. Hyperthyroid patients are rendered euthyroid before surgery with anti-
thyroid drugs  that should be continued up to the day of surgery.  
 3. Prophylactic antibioties are not used routinely  
 
Conduct of thyroidectomy  
❖ Performed under general anaesthesia  
❖ Position of the patient  
Supine with a sand bag between the scapulae.  
Head is placed on a donut cushion and neck is extended. 
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Incisions  
 1. Kocher transverse collar incision about 4 – 5cm skin incision along a skin 
crease  just 1 cm below the cricoid cartilage. 
 2. Low collar incision made 2 finger breaths above the suprasternal notch 
along a skin crease.  
 
TECHNIQUE  
1. The subcutaneous tissues and platysma are incised sharply  sub platysmal 
flaps are raised superiorly upto the level of thyroid cartilage and inferiorly  
upto the level of suprasternal notch.  
2. A self retaining retractor Jolls is applied  
3. The deep cervical fascia are divided in the midline along the entire length of 
the mobilized flaps and the thyroid gland is exposed and delivered using 
blunt dissection. 
4. On the side of the lesion, the sternohyoid muscle is separated from the 
sternothyroid by blunt dissection until the internal jugular vein and 
ansacervicalis nerve are identified. If needed, the strap muscles can be 
divided high avoiding injury to ansacervicalis and if infiltrated by tumor the 
muscle involved can be excised.  
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5. The Sternothyroid muscle is dissected off the underlying thyroid exposing 
the middle thyroid veins which are ligated & divided after retracting the 
thyroid lobe anteromedially.  
6. The fascia just cephaled to the isthmus is divided. The superior thyroid pole 
is identified by inferomedial retraction of the lobe and superior pole vessels 
are individually identified, skeletonized, ligated and divided low on the 
thyroid gland to avoid injury to the external branch of superior laryngeal 
nerve. The recurrent laryngeal nerve should be identified at the level of 
cricoid cartilage and the parathyroids with in 1cm of crossing of the inferior 
thyroid artery and the recurrent laryngeal nerve.  
7. The lower pole is mobilized by gently sweeping all tissues dorsally. Inferior 
thyroid vessels are dissected, skeletonized, ligated and divided close to the 
surface of the thyroid gland as possible to minimize devascularization of the 
Parathyroids or injury to the recurrent laryngeal nerve.  
8. If a lobectomy is to be performed, the isthmus is divided flush with the 
trachea on the contralateral side and suture ligated. For a total thyroidectomy 
the procedure is repeated on the opposite side.  
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9. After adequate hemostasis and drain placement viz optional, the strap 
muscles are reapproximated in the midline using absorbable sutures. After 
approximation of platysma, skin closure is done with sub cuticular sutures or 
clips.  
 
 Several approaches to minimally – invasive thyroidectomy such as video 
assisted thyroidectomy and endoscopic thyroidectomy via axillary incisions have 
been proposed. These methods are feasible but clear benefits over the traditional 
open approach have not been established.  
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COMPLICATIONS OF THYROID SURGERY 
 1. Primary and reactionary hemorrhage 
 2. Airway compromise due to tracheal collapse 
 3. Injury to recurrent laryngeal nerve – vocal cord dysfunction. 
 4. Injury to external laryngeal nerve – Dysphonia 
 5. Injury to Parathyroid glands-hypo calcemia 
 6. Seromas 
 7. Wound cellulitis and infection 
 8. Post operative hypothyroidism. 
 9. Keloid formation at incision site. 
 
FOLLOW UP OF THE PATIENTS 
 1. Physical Examination 
 2. Hormone Assay 
 3. Thyroid auto antibody assay in patients with lymphoeytic 
thyroiditis.  
 4. Radioactive lodine scan for malignancies, to rule out local 
recurrence or lymph node metastasis and bone scan to rule out skeletal 
metastasis.  
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 5. Post operative thyroxine support for 3 months to enable the 
remaining thyroid    to take over and to prevent compensatory hypetrophy.   
 
 6. Any delayed occurrence of goiter in the remaining lobe must be 
investigated to rule out carcinoma. Mostly it is compensatory hypertrophy 
and responds  to thyroxine supplementations.  
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OBSERVATIONS AND ANLYSIS OF RESULTS 
 In the present study 100 patients were included and majority of the patients 
were in their third, fourth and fifth decades of life.  
AGE DISTRIBUTION 
AGE IN YEARS  NO. OF PATIENTS  PERCENTAGE 
11-20 1 1% 
21-30 39 39% 
31-40 31 31% 
41-50 23 23% 
51-60 6 6% 
 
The age of the patients studied ranged from 20 years to 60 years.  
 
GENDER DISTRIBUTION 
GENDER  NO OF PATIENTS  PERCENTAGE 
Females  89 89% 
Males  11 11% 
 
89 females and 11 males out of 100 were included in this study.  
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FREQUENCY OF SYMPTOMS  
SYMPTOMS NO OF PATIENTS PERCENTAGE 
SWELLING  64 64% 
SWELLING & PAIN  4 4% 
Swelling & dysphagia  23 23% 
Swelling, Pain & 
dysphagia 
9 9% 
 
 All the 100 patients complained of a swelling in the front of their neck. 13 
patients had pain, 32 complained of some difficulty in swallowing.  
 
PHYSICAL EXAMINATION 
❖ Size of the nodule varied from 4 to 7cm  
❖ Nature of the nodule – smooth, firm, no fixity & confined to right/left lobe 
+/isthmus.  
❖ No regional lymph node enlargement  
❖ No signs of thyroid dysfunction 
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THYROID FUNCTION  
THYROID FUNCTION  NO. OF PATIENTS  PERCENTAGE  
Euthyroid  96 96% 
Hypo thyroid  4 4% 
Hyper thyroid  0 0 
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SOLITARY NODULE OF THE THYROID 
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                            SOLITARY NODULE OF THE THYROID 
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SOLITARY NODULE OF THE THYROID 
 
 
 
43 
 
 
SOLITARY NODULE OF THE THYROID 
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              Among the 100 patients 96 were euthyroid and 4 patients had mild 
elevation of the level of Sr. TSH. No case of hyperthyroidism was noted.  
 
ULTRA SONOGRAM NECK  
 All 100 patients were subjected to ultrasonogram neck and all 100 nodules 
were reported as solid areas. No area of cystic lesion or multi nodular lesion 
identified.  
 
CYTOLOGICAL ANALYSIS – FNAC  
Cytology No. of patients Percentage 
Colloid nodule  53 53% 
Adenoma  47 47% 
 
 53 cases were reported to have a colloid nodule on FNAC and 47 cases 
reported as adenomatous goiter. No case of malignancy was reported on 
cytological analysis.  
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ULTRASONOGRAM NECK  
 
 
 
 
 
 
ISOECHOIC INTRA THYROIDAL MASS – ADENOMA 
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 Computerized Tomography of neck was done in one patient, the youngest 
patient in this study, which identified the solitary nodule as a adenoma thyroid. 
Only one among the patients who was affordable was subjected to Radio active 
iodine uptake study which revealed a cold nodule. 
 
 All the 100 patients were assessed for hemi thyroidectomy under general 
anaesthesia and per operative evaluation by palpation of the contralateral lobe done 
and no evidence of nodularity in the contralateral lobe or no regional lymph node 
metastasis identified and hemithyroidectomy proceeded with in all patients.  
  
HISTOPATHOLOGICAL EXAMINATION  
 All the 100 patients underwent Hemithyroidectomy and the histopathology 
of the excised specimens tabulated.  
The incidence of malignancy was found to be 16%.  
 30% of the patients had benign adenomas of papillary and follicular types.  
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COMPUTERIZED TOMOGRAM NECK  
 
 
 
 
 
HYPODENSE LESION RIGHT LOBE – ADENOMA 
 
 
 
 
 
48 
 
CONTRAST ENHANCED COMPUTERIZED TOMOGRAM NECK  
 
 
 
 
 
 
HETEROGENEROUSLY ENHANCED LESION IN RIGHT LOBE OF 
THYROID  
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The incidence of inflammatory goiter was 3% and 4 patients showed evidence of 
toxicity in the excised specimen.  
HISTOPATHOLOGICAL EXAMINATION  
SOLITARY 
NODULE OF 
THE THYROID 
SOLITARY 
NODULE OF 
THE THYROID 
SOLITARY 
NODULE OF 
THE THYROID 
SOLITARY 
NODULE OF 
THE THYROID 
1.  Dominant nodule 
of multi nodular 
goitre  
47 47% 
2.  Papillary adenoma  17 17% 
3. Follicular 
adenoma  
13 13% 
4. Papillary 
carcinoma  
14 14% 
5. Follicular 
carcinoma  
2 2% 
6. Thyroiditis  3 3% 
7. Toxicity  4 4% 
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HISTOPATHOLOGY  
 
COLLOID NODULE  
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HISTOPATHOLOGY  
 
LYMPHOCYTIC THYROIDITIS  
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HISTOPATHOLOGY  
 
 
PAPILLARY CARCINOMA  
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HISTOPATHOLOGY  
 
 
FOLLICULAR CARCINOMA  
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AGE DISTRIBUTION OF MALIGNANT NODULES  
Age in yrs No. of Patients Percentage 
11 – 20  0 0 
21 – 30 6 37.5% 
31 – 40 4 25% 
41 – 50 4 25% 
51 – 60  2 12.5% 
 
Malignancy most common in the 3rd decade of life in this study.  
SEX DISTRIBUTION OF SOLITARY THYROID NODULE 
Sex Benign Malignant Total 
M  9 2 11 
F 75 14 89 
Total  84 16 100 
 
18.18% of  nodules in males were malignant and 15.73% of nodules were 
malignant in females.  
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POST – OPERATIVE COMPLICATIONS  
 Majority of Patients 84% had an uneventful post operative period.  
Complication No. of patients Percentage 
Hemorrhage  1 1% 
Dysphonia  4 4% 
Wound infection  1 1% 
Hypothyroidism  10  10% 
 
 One among the patients had reactionary hemorrhage and the hematoma was 
let out in the post operative period.  
 4 had transient dysphonia in the form of loss of pitch of voice which 
improved subsequently.  
 I  had wound infection and pus culture & sensitivity revealed staphylococci 
sensitive to Cephalexin.  
 10 patients among developed postoperative hypothyroidism and were given 
L – thyroxine therapy.  
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FOLLOW UP  
 
 The follow up period of the patients varied from 3 months to 12 months. 
First review after 2 weeks and second review after 6 weeks thyroid function tests 
done in all patients all at 6 weeks. More than 70 patients lost follow up after 3 
months.  
 Patients with lymphocytic thyroiditis had thyroid auto antibody assay and 
were given tablet L – thyroxine therapy.  
 Patients with post operative hypothyroidism were managed with L – 
thyroxine.  
 Among patients with malignancy, 2 lost their follow up, 8 were referred to 
higher centers for further evaluation and treatment, 2 had complete metastatic 
workup (CT Scan neck and radioactive iodine uptake study done) and completion 
thyroidectomy done. 4 patients who were not willing for further evaluation were 
managed by L- thyroxine suppression therapy.  
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DISCUSSION 
 
 Solitary nodule of the thyroids are common clinical entities which needs 
careful evaluation to correctly identify patients who need thyroidectomy.  
AGE 
 Age group in the present study ranges from 20 – 60yrs.  
 Majority of the patients, 97% were young and middle aged 21 – 50 of age.  
 The incidence of malignancy was found to be high in the 21 – 50 yrs age 
group.  
 
GENDER  
 There were 89 females and 11 males in this study.  
 The solitary nodule of the thyroid was 8 times more common in females than 
males which is very high in comparison to world statistics which show a male to 
female ratio of 1:3. 
 The incidence of malignancy was more in males than in females.  
 Males   18.18% 
 Females           15.73% 
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SOLITARY NODULE OF THE THYROID  
 
 
❖ Mean age at presentation – 36 years  
❖ More common in 3rd, 4th & 5th decades of life 
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SOLITARY NODULE OF THE THYROID 
 
GENDER DISTRIBUTION  
 
 
Solitary Nodule of the thyroid 8 times 
More common in females than males 
 
RISK FACTORS – no significant risk factor was identified  
 
 
60 
 
 
CLINICAL ASPECTS  
 At the time of admission all the patients presented with a swelling in the 
anterior aspect of the neck. 
13 patients had complaints of pain over the swelling which post operative, 
retrospective evaluation with the help of histopathology was attributed to 
thyroiditis and cystic degeneration or hemorrhage into a nodule.  
 32 patients complained of vague discomfort in neck during swallowing 
which could not be attributed to any pathology or size of the swelling.  
 On physical examination solitary nodules of thyroid of varying sizes from 4 
– 7cm confined to right or left lobe with or without involvement of the isthmus of 
thyroid were noted. All patients were clinically euthyroid.  
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SOLITARY NODULE OF THE THYROID  
 
FREQUENCY OF SYMPTOMS  
 
 
CLINICAL SYMPTOMS  
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HORMONE ASSAY FOR THYROID FUNCTION  
 Only 4 patients had hypothyroidism which was attributed to lymphocytic 
thyroiditis and multi nodular goiter diagnosed on histopathological examination 
post operatively and these patients benefited by post operative L – thyroxine 
supplementation.  
 Majority, about 96% were euthyroid at the time of admission.  
ULTRA SONOGRAM NECK  
 All 100 patients were subjected to ultrasonogram neck and all 100 nodules 
were reported as solid areas. No area of cystic lesion or multi nodular lesion 
identified. 
CYTOLOGICAL ANALYSIS  
 In fine needle aspiration cytology, the Gold standard investigation in the 
evaluation of solitary nodule of the thyroid, all 100 cases were reported as benign 
and 53 were colloid nodules and 47 were adenomas.  
 Retrospective comparison with Histopathology of excised specimen revealed 
a false negative report in FNAC in detecting malignancy in 16 cases of malignant 
nodules.  
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SOLITARY NODULE OF THE THYROID 
 
THYROID FUNCTION 
 
 
THYROID FUNCTION  
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SOLITARY NODULE OF THE THYROID 
 
FINE NEEDLE ASPIRATION CYTOLOGY 
 
 
CYTOLOGY 
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 3 colloid nodules diagnosed by FNAC revealed foci of thyroiditis in 
Histopathology.  
 3 colloid nodules and 1 case of adenomatous goiter diagnosed by FNAC 
revealed features of toxicity in Histopathology.  
 
HISTOPATHOLOGY  
 47 cases out of 100 were dominant nodules of a multinodular goitre.  
 30 cases of adenomas, 17 papillary adenomas and 13 follicular adenomas 
were noted.  
 16 cases of malignant nodules among which 14 revealed a papillary 
carcinoma and 2 cases of follicular carcinoma were diagnosed.  
 The incidence of inflammatory goiter was 3% and toxic features in colloid 
nodules and an adenoma were noted in 4 patients.  
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SPECTRUM OF SOLITARY THYROID NODULE 
 
HISTOPATHOLOGICAL EXAMINATION 
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SOLITARY NODULE OF THE THYROID 
AGE DISTRIBUTION OF MALIGNANT NODULES 
 
Age in years  
MALIGNANCY MOST COMMON IN THE THIRD DECADE  
OF LIFE IN THIS STUDY  
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SOLITARY NODULE OF THE THYROID 
 
SEX DISTRIBUTION OF SOLITARY THYROID NODULE 
 
 
GENDER 
    Malignant nodules 
    Males   18.18% 
    Females            15.73% 
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SURGERY  
 All 100 patients were posted for surgery after fitness for anaesthesia and per 
operative palpation of contralateral lobe showed no evidence of nodules and 
ipsilateral hemithyroidectomy was done.  
 
POST OPERATIVE COMPLICATIONS 
 84 Patients had an uneventful post operative period.  
 I  had reactionary hemorrhage and another one had wound infection which 
were managed appropriately.  
 4 suffered transient dysphonia that settled without specific therapy.  
 10 cases of post operative hypothyroidism was detected and the patients had 
either inflammatory goiter or a multinodular goiter and were managed with L – 
thyroxine therapy.  
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SOLITARY NODULE OF THE THYROID 
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FOLLOW UP  
 All patients were followed up for a period of 3 months to 1 year.  
 During the follow up patients had thorough physical examination, TSH and 
thyroxine assay and thyroxine therapy for selected patients.  
 Patients with lymphocytic thyroiditis had thyroid auto antibody assay and 
were given tablet L – thyroxine therapy. Among patients with malignancy, 2 lost 
their follow up, 8 were referred to higher centers for further evaluation and 
treatment, 2 had complete metastatic workup (CT Scan neck and radioactive iodine 
uptake study done) and completion thyroidectomy done. 4 patients who were not 
willing for further evaluation were managed by L – thyroxine suppression therapy.  
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CONCLUSION  
 
1. Solitary nodule of the thyroid was found to be more common in young and 
middle aged patients.  
2. Solitary nodule of the thyroid was 8 times more common in females than 
males.  
3. Majority of the solitary nodule were dominant nodules of a multinodular 
goiter.  
4. In the individuals admitted with solitary nodule of thyroid and managed by 
hemithyroidectomy, the incidence of malignancy was 16%.  
5. The incidence of malignancy in solitary nodule of thyroid in males exceeds 
that of females the ratio being, 18:15. 
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SUMMARY  
 A total of 100 consecutive patients with solitary nodule of the thyroid 
admitted were evaluated clinically, biochemically, radiologically and 
cytologically.  
 The patients underwent Hyemithyroidectomy and the histopathology of the 
excised specimens were studied to evaluate the incidence of malignancy.  
 The incidence of malignancy in solitary nodule of the thyroid in the present 
study was 16% and incidence of malignancy in males exceeds that of females.  
 Fine needle aspiration cytology, now considered as the gold standard 
diagnostic test in the evaluation of a thyroid nodule revealed false negative 
report in 16 patients in this study. Ultra sonogram and nuclear scans are also 
useful tests, but are best used in conjuction with fine needle aspiration cytology.  
 Solitary nodule of the thyroid is a common entity whereas malignancy 
although rare needs a selective approach for further management and follow up.  
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PROFORMA 
 
Name  : Age :    Yrs   Sex: M/F  I.P. No:  
Occupation :  
Address  :   Date of Admission  :  
     Date of Surgery  : 
     Date of Discharge  :  
Final Diagnosis  
 
Clinical symptoms at the time of admission   Duration  
 Swelling in the neck  
 Pain over the swelling  
 Dysphagia / Dyspnoea / Dysphonia  
 Weight gain / Weight loss 
 Increased / Poor appetite  
 Increased sleep / Loss of sleep  
 Constipation / Diarrhoea  
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 Tremors / Sweating  
 Palpitations / Chest pain  
 Fever  
Menstrual History in Females  
Past History  
 Similar neck swelling  
 Head neck irradiation  
 Drug intake  
 Previous surgeries  
  General examination  
  Consciousness  
  Build  
  Pallor  
  Facies & Eyesigns  
  Skin  
  Tremors  
  Vital Signs  
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Local Examination: Neck  
Nodule  
 -  Size   Firm / Hard   Fixity  
Rest of the Gland – Palpable / Impalpable  
Movement with Deglutition  
 
Tracheal Position  
Regional Lymph Nodes  
 
Investigations  
Routine       Specific  
1. Complete hemogram     Erythrocyte sedimentation rate  
2. Urine analysis      Thyroid Function Test  
3. Biochemical investigations   Ultra sonogram neck  
4. Thyroid function tests – Sr TSH, T3 T4 X- ray neck AP, Lateral views  
5. Chest  X – ray      Indirect Laryngoscopy  
6. ECG                CT Scan & MRI neck  
                Radio Iodine uptake study  
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Surgery  
Hemithyroidectomy R/L  
Operative Notes  
 
Histo Pathological Examination 
Completion thyroidectomy  
Post operative period  
Follow up  
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S.No Name I.P. No. Age Sex Thyroid Function F.N.A.C
Surgery Hemi 
Thyroidectomy
Histopathological Report 
Post Operative 
Complications 
Follow up 3 Months - 1 
Year
1 SARASWATHI 239184 45 F Eu Thyroid Adenoma Right Papillary Adenoma Uneventful Routine
2 MEENAMBAL 224336 35 F Eu Thyroid Colloid Nodule Left Multi Nodular Goiter Hypothyroidism Routine
3 RANI 242411 39 F Eu Thyroid Colloid Nodule Left Multi Nodular Goiter Uneventful Routine
4 JEYA 242426 24 F Eu Thyroid Adenoma Right Follicular Adenoma Uneventful Routine
5 JAYAKODI 244122 25 F Eu Thyroid Colloid Nodule Right Multi Nodular Goiter Uneventful Routine
6 SAROJA 241843 25 F Eu Thyroid Adenoma Right Paillary Adenoma Dysphonia Routine
7 BANUMATHY 245249 40 F Eu Thyroid Adenoma Left Paillary Adenoma Uneventful Routine
8 SAKTHI 246677 30 F Eu Thyroid Colloid Nodule Left Multi Nodular Goiter Hypothyroidism Routine
9 PAPATHY 248345 45 F Eu Thyroid Adenoma Right Paillary Adenoma Dysphonia Routine
10 SUBBULAXMI 49575 44 F Eu Thyroid Adenoma Left Paillary Adenoma Uneventful Higher Center Referral
11 ROSALIN 252882 40 F Eu Thyroid Colloid Nodule Left Multi Nodular Goiter Uneventful Routine
12 RENGANAYAKI 254804 39 F Eu Thyroid Colloid Nodule Right Multi Nodular Goiter Uneventful Routine
13 RAJESHWARI 254890 25 F Eu Thyroid Colloid Nodule Right Multi Nodular Goiter Uneventful Routine
14 CHITRA 257199 25 F Eu Thyroid Colloid Nodule Right Multi Nodular Goiter Uneventful Routine
15 SIVA BAKIYAM 268765 50 F Eu Thyroid Adenoma Left Paillary Adenoma Uneventful Routine
16 SATHYABAMA 258414 20 F Eu Thyroid Colloid Nodule Left Multi Nodular Goiter Uneventful Routine
17 KIRUBARANI 256957 23 F Eu Thyroid Colloid Nodule Right Multi Nodular Goiter Uneventful Routine
18 BHOOMA DEVI 260704 30 F Eu Thyroid Adenoma Left Follicular Adenoma Dysphonia Completion Thyroidectomy
19 JOSPINE MARY 262477 27 F Eu Thyroid Colloid Nodule Left Multi Nodular Goiter Uneventful Routine
20 LAKSHMI 261714 50 F Eu Thyroid Adenoma Right Paillary Adenoma Uneventful Routine
21 SELVI 264539 30 F Eu Thyroid Colloid Nodule Right Multi Nodular Goiter Dysphonia Routine
22 MEENAMBAL 265642 35 F Eu Thyroid Adenoma Left Paillary Adenoma Wound Infection Routine
23 ROONIKAM 265329 35 F Eu Thyroid Colloid Nodule Left Multi Nodular Goiter Uneventful Routine
24 SHANTHI 267932 24 F Eu Thyroid Adenoma Right Paillary Adenoma Uneventful Routine
25 SIGAPPAYI 267413 40 F Eu Thyroid Adenoma Right Paillary Adenoma Uneventful Routine
26 SARAMMAL 269497 33 F Eu Thyroid Colloid Nodule Right Multi Nodular Goiter Uneventful Routine
27 POONGOTHAI 288184 24 F Eu Thyroid Adenoma Left Paillary Adenoma Uneventful Routine
28 LOGAMBAL 276928 40 F Eu Thyroid Adenoma Left Paillary Adenoma Uneventful Routine
29 AMSAVALLI 276972 45 F Hypo Thyroid Adenoma Right Paillary Adenoma Uneventful Higher Center Referral
30 FATHIMA 278059 47 F Eu Thyroid Colloid Nodule Left Lymphoytic Thyroidits Uneventful L - Thyroxine
31 VASANTHA 280664 29 F Eu Thyroid Colloid Nodule Left Multi Nodular Goiter Uneventful Routine
32 VEMBU 282483 42 F Eu Thyroid Colloid Nodule Right Multi Nodular Goiter Hypothyroidism Routine
33 SOWHAR NISHA 289947 38 F Eu Thyroid Colloid Nodule Right Multi Nodular Goiter Uneventful Routine
34 JANAKI AMMAL 269974 60 F Eu Thyroid Adenoma Left Paillary Adenoma Uneventful Higher Center Referral
35 VELLAIAMMAL 272641 39 F Eu Thyroid Colloid Nodule Left Multi Nodular Goiter Uneventful Routine
36 RENGANAYAKI 272624 60 F Eu Thyroid Adenoma Right Follicular Adenoma Reactionary Hemorrhage Routine
37 MAHALAKSHMI 273195 22 F Eu Thyroid Colloid Nodule Right Multi Nodular Goiter Uneventful Routine
38 SIVANANDHAM 273205 43 M Eu Thyroid Colloid Nodule Left Multi Nodular Goiter Uneventful Routine
39 VAIRASELVI 273831 27 F Eu Thyroid Colloid Nodule Left Multi Nodular Goiter Uneventful Routine
40 RATHI 274218 36 F Eu Thyroid Colloid Nodule Right Multi Nodular Goiter Uneventful Routine
41 ROJA 275245 40 F Eu Thyroid Adenoma Right Paillary Adenoma Uneventful Higher Center Referral
42 MANIMEGALAI 273940 38 F Eu Thyroid Colloid Nodule Left Multi Nodular Goiter Uneventful Routine
43 JONES MARY 275572 28 F Eu Thyroid Colloid Nodule Left Multi Nodular Goiter Uneventful Routine
44 SUDHA 276606 39 F Eu Thyroid Colloid Nodule Right Multi Nodular Goiter Hypothyroidism Routine
45 SOMYYA 276304 29 F Eu Thyroid Colloid Nodule Right Multi Nodular Goiter Uneventful Routine
46 RAJATHI 276318 31 F Eu Thyroid Colloid Nodule Left Multi Nodular Goiter Uneventful Routine
47 MALLIGA 276973 35 F Eu Thyroid Adenoma Left Paillary Adenoma Uneventful Higher Center Referral
48 MADHAVI 276949 42 M Eu Thyroid Adenoma Right Paillary Adenoma Uneventful Routine
49 KAVITHA 287280 25 F Eu Thyroid Adenoma Right Paillary Adenoma Uneventful Routine
50 JANAKI 289370 43 F Eu Thyroid Colloid Nodule Left Multi Nodular Goiter Hypothyroidism Routine
S.No Name I.P. No. Age Sex Thyroid Function F.N.A.C
Surgery Hemi 
Thyroidectomy
Histopathological 
Report 
Post Operative 
Complications 
51 VIJAYA 289060 37 F Eu Thyroid Colloid Nodule Left Multi Nodular Goiter Uneventful
52 DAMAYANTHI 291216 30 F Eu Thyroid Adenoma Right Paillary Adenoma Uneventful
53 SELLAMANI 201290 23 F Eu Thyroid Colloid Nodule Right Multi Nodular Goiter Uneventful
54 SELVI 203090 33 F Hypo Thyroid Colloid Nodule Left Lymphoytic Thyroidits Uneventful
55 KANAGAM 201004 38 F Eu Thyroid Adenoma Left Follicular Adenoma Uneventful
56 JOTHI 203782 38 F Eu Thyroid Adenoma Right Follicular Adenoma Uneventful
57 AMARAVATHY 205499 60 F Eu Thyroid Adenoma Right Follicular Adenoma Uneventful
58 JEGANATHAN 208642 30 M Eu Thyroid Adenoma Left Follicular Adenoma Uneventful
59 SOUNDARAJAN 215816 45 M Eu Thyroid Adenoma Left Paillary Adenoma Uneventful
60 NITHYADEVI 205039 25 F Eu Thyroid Colloid Nodule Right Multi Nodular Goiter Uneventful
61 KARUPPAYEE 205603 30 F Hypo Thyroid Colloid Nodule Right Lymphoytic Thyroidits Uneventful
62 SAVITHRI 205741 40 F Eu Thyroid Colloid Nodule Left Multi Nodular Goiter Uneventful
63 PAPPATHI 206918 36 F Eu Thyroid Colloid Nodule Left Multi Nodular Goiter Hypothyroidism 
64 INDIRA 207881 29 F Eu Thyroid Colloid Nodule Right Toxicity Hypothyroidism 
65 MAHESHWARI 209035 35 F Hypo Thyroid Colloid Nodule Right Multi Nodular Goiter Uneventful
66 VASANTHA 211232 38 F Eu Thyroid Colloid Nodule Left Multi Nodular Goiter Uneventful
67 RENGANAYAKI 216002 45 F Eu Thyroid Adenoma Left Multi Nodular Goiter Uneventful
68 VEERAMMAL 221240 60 F Eu Thyroid Adenoma Right Toxicity Dysphonia
69 CHITRA 222466 30 F Eu Thyroid Adenoma Right Paillary Adenoma Uneventful
70 CHANDRA 221791 52 F Eu Thyroid Adenoma Left Paillary Adenoma Uneventful
71 SUMATHI 227333 28 F Eu Thyroid Adenoma Left Multi Nodular Goiter Dysphonia
72 RAJALAKSHMI 226927 42 F Eu Thyroid Adenoma Right Follicular Adenoma Wound Infection
73 CHITRA 229336 26 F Eu Thyroid Adenoma Right Multi Nodular Goiter Uneventful
74 MALARKODI 229681 49 F Eu Thyroid Adenoma Left Follicular Adenoma Uneventful
75 SUNDARI 229429 30 F Eu Thyroid Adenoma Left Follicular Adenoma Uneventful
76 MAHALAKSHMI 231241 25 F Eu Thyroid Adenoma Right Follicular Adenoma Uneventful
77 MUTHAMMAL 231185 25 F Eu Thyroid Colloid Nodule Right Multi Nodular Goiter Hypothyroidism 
78 SUMATHY 231442 30 F Eu Thyroid Colloid Nodule Left Multi Nodular Goiter Uneventful
81 MUTHUSAMY 234286 45 M Eu Thyroid cc Right Multi Nodular Goiter Hypothyroidism Routine
82 REETA MARY 235277 50 F Eu Thyroid Adenoma Left Paillary Adenoma Uneventful Lost Follow Up
83 MAHESWARI 233959 30 F Eu Thyroid Adenoma Left Paillary Adenoma Uneventful T4 - Suppression
84 VIJAYARANI 237367 23 F Eu Thyroid Adenoma Right Toxicity Uneventful Normal TFT - Follow Up
85 JEYASEELAN 238208 44 M Eu Thyroid c Right Toxicity Uneventful Normal TFT - Follow Up
86 GANESAN 236198 44 M Eu Thyroid Adenoma Left Paillary Adenoma Uneventful Routine
87 SARAL 228177 39 F Eu Thyroid c Left Multi Nodular Goiter Uneventful Routine
88 NOORJAHAN 239351 48 F Eu Thyroid c Right Multi Nodular Goiter Hypothyroidism Routine
89 DHAVAMANI 234123 33 F Eu Thyroid c Right Multi Nodular Goiter Uneventful Routine
90 MALLIKA 240255 31 F Eu Thyroid Adenoma Left Paillary Adenoma Uneventful Routine
91 KANNAN 244065 47 M Eu Thyroid Adenoma Left Paillary Adenoma Uneventful Routine
92 SANTHOSH 241874 50 M Eu Thyroid c Right Multi Nodular Goiter Uneventful Routine
93 KALAISELVI 241992 35 F Eu Thyroid Adenoma Right Paillary Adenoma Uneventful T4 - Suppression
94 AARTHY 253434 40 F Eu Thyroid Adenoma Left Paillary Adenoma Uneventful Routine
95 RAMYA 247756 28 F Eu Thyroid Adenoma Left Paillary Adenoma Uneventful T4 - Suppression
96 VARSHA 246724 21 F Eu Thyroid Adenoma Right Follicular Adenoma Uneventful Routine
97 SUMITHRA 246823 30 F Eu Thyroid Adenoma Right Follicular Adenoma Uneventful Routine
98 RAJATHY 243847 21 F Eu Thyroid Adenoma Left Follicular Adenoma Uneventful Routine
99 RAJESH KUMAR 250401 24 M Eu Thyroid Adenoma Left Paillary Adenoma Uneventful T4 - Suppression
100 MEENAKSHI 245958 37 F Eu Thyroid Adenoma Right Follicular Adenoma Uneventful Routine
